Related Experiment Video
Updated: Feb 5, 2026
13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
9.3K
Exploring the mechanisms behind long noncoding RNAs and cancer
Maggie M Balas1,2,3, Aaron M Johnson1,2,3
1Molecular Biology Program, University of Colorado Denver Anschutz Medical Campus 12801 East 17th Ave., Aurora, CO, United States.
Non-Coding RNA Research
|September 4, 2018
Summary
Long noncoding RNAs (lncRNAs) are key regulators in gene expression and cancer. Understanding their specific roles and context-dependent mechanisms is crucial for developing novel cancer therapies and diagnostics.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in gene regulation.
- Aberrant lncRNA expression is frequently observed in various cancer types, correlating with disease progression and patient outcomes.
Purpose of the Study:
- To review the molecular mechanisms of lncRNAs in cancer pathways.
- To highlight the context-dependent nature of lncRNA functions.
- To explore the potential of lncRNAs as therapeutic targets and diagnostic markers.
Main Methods:
- Literature review focusing on lncRNA mechanisms in cancer.
- Analysis of well-studied lncRNAs with defined roles in tumorigenesis.
- Discussion of context-specific lncRNA functions.
Main Results:
- lncRNAs play significant roles in gene regulation and are implicated in cancer development and progression.
- Discriminating functional lncRNAs from non-functional transcripts remains a challenge.
- lncRNA mechanisms are often context-dependent, varying with cell type and environment.
Conclusions:
- Detailed understanding of lncRNA molecular mechanisms is essential for advancing cancer research.
- lncRNAs hold promise as targets for novel cancer therapies and diagnostics.
- Further research into context-specific lncRNA functions will refine their clinical applications.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
02:39lncRNA - Long Non-coding RNAs
3.7K
3.7K
02:57piRNA - Piwi-interacting RNAs
7.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.7K
02:30siRNA - Small Interfering RNAs
18.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.7K
02:53Adaptive Mechanisms in Cancer Cells
7.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
01:51Mechanisms of Retrovirus-induced Cancers
7.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K